These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression. Hendricksen M; Thomas AJ; Ferrier IN; Ince P; O'Brien JT Am J Psychiatry; 2004 Jun; 161(6):1096-102. PubMed ID: 15169699 [TBL] [Abstract][Full Text] [Related]
3. The evolution of Alzheimer's disease-related cytoskeletal pathology in the human raphe nuclei. Rüb U; Del Tredici K; Schultz C; Thal DR; Braak E; Braak H Neuropathol Appl Neurobiol; 2000 Dec; 26(6):553-67. PubMed ID: 11123722 [TBL] [Abstract][Full Text] [Related]
4. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset? Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H; Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444 [TBL] [Abstract][Full Text] [Related]
5. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons. Yamamoto T; Hirano A Ann Neurol; 1985 Jun; 17(6):573-7. PubMed ID: 4026228 [TBL] [Abstract][Full Text] [Related]
6. The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology. Rüb U; Del Tredici K; Schultz C; Thal DR; Braak E; Braak H Acta Neuropathol; 2001 Jun; 101(6):555-64. PubMed ID: 11515783 [TBL] [Abstract][Full Text] [Related]
7. The neuropathology of aminergic nuclei in Alzheimer's disease. Zweig RM; Ross CA; Hedreen JC; Steele C; Cardillo JE; Whitehouse PJ; Folstein MF; Price DL Ann Neurol; 1988 Aug; 24(2):233-42. PubMed ID: 3178178 [TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes. Chen CP; Eastwood SL; Hope T; McDonald B; Francis PT; Esiri MM Neuropathol Appl Neurobiol; 2000 Aug; 26(4):347-55. PubMed ID: 10931368 [TBL] [Abstract][Full Text] [Related]
10. Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims. Underwood MD; Khaibulina AA; Ellis SP; Moran A; Rice PM; Mann JJ; Arango V Biol Psychiatry; 1999 Aug; 46(4):473-83. PubMed ID: 10459396 [TBL] [Abstract][Full Text] [Related]
11. Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. Samuel W; Galasko D; Masliah E; Hansen LA J Neuropathol Exp Neurol; 1996 Jan; 55(1):44-52. PubMed ID: 8558171 [TBL] [Abstract][Full Text] [Related]
12. Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia. Bancher C; Jellinger K; Lassmann H; Fischer P; Leblhuber F Eur Arch Psychiatry Clin Neurosci; 1996; 246(3):137-46. PubMed ID: 8739399 [TBL] [Abstract][Full Text] [Related]
13. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients. Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843 [TBL] [Abstract][Full Text] [Related]
14. Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study. Marner L; Frokjaer VG; Kalbitzer J; Lehel S; Madsen K; Baaré WF; Knudsen GM; Hasselbalch SG Neurobiol Aging; 2012 Mar; 33(3):479-87. PubMed ID: 20510480 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease. Kumar NT; Liestøl K; Løberg EM; Reims HM; Mæhlen J Virchows Arch; 2015 Aug; 467(2):225-35. PubMed ID: 25898889 [TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex. Yilmazer-Hanke DM Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108 [TBL] [Abstract][Full Text] [Related]
19. Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care. Trillo L; Das D; Hsieh W; Medina B; Moghadam S; Lin B; Dang V; Sanchez MM; De Miguel Z; Ashford JW; Salehi A Neurosci Biobehav Rev; 2013 Sep; 37(8):1363-79. PubMed ID: 23707776 [TBL] [Abstract][Full Text] [Related]
20. Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis. Theofilas P; Dunlop S; Heinsen H; Grinberg LT J Alzheimers Dis; 2015; 46(1):17-34. PubMed ID: 25720408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]